Ligation of TLR7 on CD19+CD1dhi B cells suppresses allergic lung inflammation via regulatory T cells

European Journal of Immunology

Volumn 45, Issue 6, 2015, Pages 1842-1854

  Khan, Adnan R ^a   Amu, Sylvie ^a   Saunders, Sean P ^a   Hams, Emily ^a   Blackshields, Gordon ^b   Leonard, Martin O ^c,g   Weaver, Casey T ^d   Sparwasser, Tim ^e   Sheils, Orla ^b   Fallon, Padraic G ^a,f  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

^d University of Alabama at Birmingham   (United States)

^e INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

^f OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^g PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

AHR; Helminth; IL 10; Regulatory B cells; TLR7 Treg cells

Indexed keywords

CD19 ANTIGEN; CD1D ANTIGEN; INTERLEUKIN 10; TOLL LIKE RECEPTOR 7; TRANSCRIPTION FACTOR FOXP3; OVALBUMIN; PROTEIN BINDING;

ALLERGIC AIRWAY INFLAMMATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL POPULATION; CELL SELECTION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENSITOMETRY; DISEASE PREDISPOSITION; FLOW CYTOMETRY; GENE EXPRESSION; GERMINAL CENTER; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG FUNCTION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SCHISTOSOMA MANSONI; SUPPRESSOR CELL; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; HYPERSENSITIVITY; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PARASITOLOGY; RESPIRATORY TRACT ALLERGY; SCHISTOSOMIASIS MANSONI; UPREGULATION;

ANIMALS; ANTIGENS, CD19; ANTIGENS, CD1D; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; HUMANS; HYPERSENSITIVITY; INTERLEUKIN-10; MICE; MICE, KNOCKOUT; OVALBUMIN; PNEUMONIA; PROTEIN BINDING; RESPIRATORY HYPERSENSITIVITY; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTOR 7; UP-REGULATION;

EID: 84930416988     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201445211     Document Type: Article

References (64)

1. Mauri, C. and Bosma, A., Immune regulatory function of B cells. Annu. Rev. Immunol. 2012. 30: 221-241.
2. Ries, S., Hilgenberg, E., Lampropoulou, V., Shen, P., Dang, V. D., Wilantri, S., Sakwa, I. et al., B-type suppression: a role played by "regulatory B cells" or "regulatory plasma cells"? Eur. J. Immunol. 2014. 44: 1251-1257.
3. Mizoguchi, A., Mizoguchi, E., Takedatsu, H., Blumberg, R. S. and Bhan, A. K., Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 2002. 16: 219-230.
4. Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D. and Anderton, S. M., B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 2002. 3: 944-950.
5. Bouaziz, J.-D., Le Buanec, H., Saussine, A., Bensussan, A. and Bagot, M., IL-10 producing regulatory B cells in mice and humans: state of the art. Curr. Mol. Med. 2012. 12: 519-527.
6. Kalampokis, I., Yoshizaki, A. and Tedder, T. F., IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis Res. Ther. 2013. 15(Suppl 1): S1.
7. Candando, K. M., Lykken, J. M. and Tedder, T. F., B10 cell regulation of health and disease. Immunol. Rev. 2014. 259: 259-272.
8. Yanaba, K., Bouaziz, J.-D., Haas, K. M., Poe, J. C., Fujimoto, M. and Tedder, T. F., A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008. 28: 639-650.
9. Yoshizaki, A., Miyagaki, T., DiLillo, D. J., Matsushita, T., Horikawa, M., Kountikov, E. I., Spolski, R. et al., Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 2012. 491: 264-268.
10. Amu, S., Saunders, S. P., Kronenberg, M., Mangan, N. E., Atzberger, A. and Fallon, P. G., Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J. Allergy Clin. Immunol. 2010. 125: 1114-1124.
11. Mangan, N. E., Fallon, R. E., Smith, P., van Rooijen, N., McKenzie, A. N. and Fallon, P. G., Helminth infection protects mice from anaphylaxis via IL-10-producing B cells. J. Immunol. 2004. 173: 6346-6356.
12. Wilson, M. S., Taylor, M. D., O'Gorman, M. T., Balic, A., Barr, T. A., Filbey, K., Anderton, S. M. et al., Helminth-induced CD19+CD23hi B cells modulate experimental allergic and autoimmune inflammation. Eur. J. Immunol. 2010. 40: 1682-1696.
13. Yanaba, K., Kamata, M., Ishiura, N., Shibata, S., Asano, Y., Tada, Y., Sugaya, M. et al., Regulatory B cells suppress imiquimod-induced, psoriasis-like skin inflammation. J. Leukoc. Biol. 2013. 94: 1-11.
14. Blair, P. A., Norena, L. Y., Flores-Borja, F., Rawlings, D. J., Isenberg, D. A., Ehrenstein, M. R., Mauri, C. et al., CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 2010. 32: 129-140.
15. Vander Vlugt, L. E., Labuda, L. A., Ozir-Fazalalikhan, A., Lievers, E., Gloudemans, A. K., Liu, K. Y., Barr, T. A. et al., Schistosomes induce regulatory features in human and mouse CD1d(hi) B cells: inhibition of allergic inflammation by IL-10 and regulatory T cells. PLoS One 2012. 7: e30883.
16. Clingan, J. M. and Matloubian, M., B cell-intrinsic TLR7 signaling is required for optimal B cell responses during chronic viral infection. J. Immunol. 2013. 191: 810-818.
17. Vinuesa, C. G. and Chang, P.-P., Innate B cell helpers reveal novel types of antibody responses. Nat. Immunol. 2013. 14: 119-126.
18. Browne, E. P., Regulation of B-cell responses by Toll-like receptors. Immunology 2012. 136: 370-379.
19. Khan, A. R., Amu, S., Saunders, S. P. and Fallon, P. G., The generation of regulatory B cells by helminth parasites. Methods Mol. Biol. 2014. 1190: 143-162.
20. Matsushita, T., Yanaba, K., Bouaziz, J.-D., Fujimoto, M. and Tedder, T. F., Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 2008. 118: 3420-3430.
21. Yang, M., Deng, J., Liu, Y., Ko, K.-H., Wang, X., Jiao, Z., Wang, S. et al., IL-10-producing regulatory B10 cells ameliorate collagen-induced arthritis via suppressing Th17 cell generation. Am. J. Pathol. 2012. 180: 2375-2385.
22. Venugopal, P. G., Nutman, T. B. and Semnani, R. T., Activation and regulation of Toll-Like receptors (TLRs) by helminth parasites. Immunol. Res. 2008. 43: 252-263.
23. Smith, P., Mangan, N. E. and Fallon, P. G., Generation of parasite antigens for use in Toll-like receptor research. Methods Mol. Biol. 2009. 517: 401-413.
24. Gorden, K. B., Gorski, K. S., Gibson, S. J., Kedl, R. M., Kieper, W. C., Qiu, X., Tomai, M. A. et al., Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J. Immunol. 2005. 174: 1259-1268.
25. Smits, E. L. J. M., Ponsaerts, P., Berneman, Z. N. and Van Tendeloo, V. F. I., The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy. Oncologist 2008. 13: 859-875.
26. Govindaraj, R. G., Manavalan, B., Basith, S. and Choi, S., Comparative analysis of species-specific ligand recognition in Toll-like receptor 8 signaling: a hypothesis. PLoS One 2011. 6: e25118.
27. Barr, T. A., Brown, S., Ryan, G., Zhao, J. and Gray, D., TLR-mediated stimulation of APC: distinct cytokine responses of B cells and dendritic cells. Eur. J. Immunol. 2007. 37: 3040-3053.
28. Evans, J. G., Chavez-Rueda, K. A., Eddaoudi, A., Meyer-Bahlburg, A., Rawlings, D. J., Ehrenstein, M. R. and Mauri, C., Novel suppressive function of transitional 2 B cells in experimental arthritis. J. Immunol. 2007. 178: 7868-7878.
29. Bouaziz, J.-D., Calbo, S., Maho-Vaillant, M., Saussine, A., Bagot, M., Bensussan, A. and Musette, P., IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur. J. Immunol. 2010. 40: 2686-2691.
30. Van, L. P., Bardel, E., Gregoire, S., Vanoirbeek, J., Schneider, E., Dy, M. and Thieblemont, N., Treatment with the TLR7 agonist R848 induces regulatory T-cell-mediated suppression of established asthma symptoms. Eur. J. Immunol. 2011. 41: 1992-1999.
31. Grela, F., Aumeunier, A., Bardel, E., Van, L. P., Bourgeois, E., Vanoirbeek, J., Leite-de-Moraes, M. et al., The TLR7 agonist R848 alleviates allergic inflammation by targeting invariant NKT cells to produce IFN-gamma. J. Immunol. 2010. 186: 284-290.
32. Bilate, A. M. and Lafaille, J. J., Induced CD4+Foxp3+ regulatory T cells in immune tolerance. Annu. Rev. Immunol. 2012. 30: 733-758.
33. Kessel, A., Haj, T., Peri, R., Snir, A., Melamed, D., Sabo, E. and Toubi, E., Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells. Autoimmun. Rev. 2012. 11: 670-677.
34. Everts, B., Adegnika, A. A., Kruize, Y. C. M., Smits, H. H., Kremsner, P. G. and Yazdanbakhsh, M., Functional impairment of human myeloid dendritic cells during Schistosoma haematobium infection. PLoS Negl. Trop. Dis. 2010. 4: e667.
35. Kobayashi, K., Hernandez, L. D., Galán, J. E., Janeway, C. A., Medzhitov, R. and Flavell, R. A., IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002. 110: 191-202.
36. Carmody, R. J., Ruan, Q., Palmer, S., Hilliard, B. and Chen, Y. H., Negative regulation of toll-like receptor signaling by NF-kappaB p50 ubiquitination blockade. Science 2007. 317: 675-678.
37. Yan, Q., Carmody, R. J., Qu, Z., Ruan, Q., Jager, J., Mullican, S. E., Lazar, M. A. et al., Nuclear factor-κB binding motifs specify Toll-like receptor-induced gene repression through an inducible repressosome. Proc. Natl. Acad. Sci. USA 2012. 109: 14140-14145.
38. Walter, A., Schäfer, M., Cecconi, V., Matter, C., Urosevic-Maiwald, M., Belloni, B., Schönewolf, N. et al., Aldara activates TLR7-independent immune defence. Nat. Commun. 2013. 4: 1560.
39. Rosser, E. C., Blair, P. A. and Mauri, C., Cellular targets of regulatory B cell-mediated suppression. Mol. Immunol. 2014. 62: 296-304.
40. Bikker, A., Kruize, A. A., van der Wurff-Jacobs, K. M. G., Peters, R. P., Kleinjan, M., Redegeld, F., de Jager, W. et al., Interleukin-7 and Toll-like receptor 7 induce synergistic B cell and T cell activation. PLoS One 2014. 9: e94756.
41. LeBien, T. W. and Tedder, T. F., B lymphocytes: how they develop and function. Blood 2008. 112: 1570-1580.
42. Klinker, M. W. and Lundy, S. K., Multiple mechanisms of immune suppression by B lymphocytes. Mol. Med. 2012. 18: 123-137.
43. Singh, A., Carson, W. F., Secor, E. R., Guernsey, L. A., Flavell, R. A., Clark, R. B., Thrall, R. S. et al., Regulatory role of B cells in a murine model of allergic airway disease. J. Immunol. 2008. 180: 7318-7326.
44. Shah, S. and Qiao, L., Resting B cells expand a CD4+CD25+Foxp3+ Treg population via TGF-beta3. Eur. J. Immunol. 2008. 38: 2488-2498.
45. Lee, J. H., Noh, J., Noh, G., Choi, W. S., Cho, S. and Lee, S. S., Allergen-specific transforming growth factor-β-producing CD19+CD5+ regulatory B-cell (Br3) responses in human late eczematous allergic reactions to cow's milk. J. Interferon Cytokine Res. 2011. 31: 441-449.
46. Natarajan, P., Singh, A., McNamara, J. T., Secor, E. R., Guernsey, L. A., Thrall, R. S. and Schramm, C. M., Regulatory B cells from hilar lymph nodes of tolerant mice in a murine model of allergic airway disease are CD5+, express TGF-β, and co-localize with CD4+Foxp3+ T cells. Mucosal. Immunol. 2012. 5: 691-701.
47. Shen, P., Roch, T., Lampropoulou, V., O'Connor, R. A., Stervbo, U., Hilgenberg, E., Ries, S. et al., IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 2014. 507: 366-370.
48. Wang, R.-X., Yu, C.-R., Dambuza, I. M., Mahdi, R. M., Dolinska, M. B., Sergeev, Y. V., Wingfield, P. T. et al., Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat. Med. 2014. 20: 633-641.
49. Khan, A. R., Hams, E., Sparwasser, T., Weaver, C., Fallon, G. and Fallon, P. G., PD-L1hi B cells are critical regulators of humoral immunity. Nat. Commun. 2015. 6: 5997.
50. Das, A., Ellis, G., Pallant, C., Lopes, A. R., Khanna, P., Peppa, D., Chen, A. et al., IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. J. Immunol. 2012. 189: 3925-3935.
51. Lin, W., Cerny, D., Chua, E., Duan, K., Yi, J. T. J., Shadan, N. B., Lum, J. et al., Human regulatory B cells combine phenotypic and genetic hallmarks with a distinct differentiation fate. J. Immunol. 2014. 193: 2258-2266.
52. O'Neill, L. A. J, Golenbock, D. and Bowie, A. G., The history of Toll-like receptors-redefining innate immunity. Nat. Rev. Immunol. 2013. 13: 453-460.
53. Soni, C., Wong, E. B., Domeier, P. P., Khan, T. N., Satoh, T., Akira, S. and Rahman, Z. S. M., B cell-intrinsic TLR7 signaling is essential for the development of spontaneous germinal centers. J. Immunol. 2014. 193: 4400-4414.
54. Vultaggio, A., Nencini, F., Pratesi, S., Maggi, L., Guarna, A., Annunziato, F., Romagnani, S. et al., The TLR7 ligand 9-benzyl-2-butoxy-8-hydroxy adenine inhibits IL-17 response by eliciting IL-10 and IL-10-inducing cytokines. J. Immunol. 2011. 186: 4707-4715.
55. Drake, M. G., Kaufman, E. H., Fryer, A. D. and Jacoby, D. B., The therapeutic potential of Toll-like receptor 7 stimulation in asthma. Inflamm. Allergy - Drug Targets 2012. 11: 484-491.
56. Møller-Larsen, S., Nyegaard, M., Haagerup, A., Vestbo, J., Kruse, T. A. and Børglum, A. D., Association analysis identifies TLR7 and TLR8 as novel risk genes in asthma and related disorders. Thorax 2008. 63: 1064-1069.
57. Roponen, M., Yerkovich, S. T., Hollams, E., Sly, P. D., Holt, P. G. and Upham, J. W., Toll-like receptor 7 function is reduced in adolescents with asthma. Eur. Respir. J. 2010. 35: 64-71.
58. Matsui, H., Tomizawa, H., Eiho, K., Kashiwazaki, Y., Edwards, S., Biffen, M., Bell, J. P. et al., Mechanism of action of inhibition of allergic immune responses by a novel antedrug TLR7 agonist. J. Immunol. 2012. 189: 5194-5205.
59. Edwards, S., Jones, C., Leishman, A. J., Young, B. W., Matsui, H., Tomizawa, H., Murray, C. M. et al., TLR7 stimulation of APCs results in inhibition of IL-5 through type I IFN and Notch signaling pathways in human peripheral blood mononuclear cells. J. Immunol. 2013. 190: 2585-2592.
60. Maynard, C. L., Harrington, L. E., Janowski, K. M., Oliver, J. R., Zindl, C. L., Rudensky, A. Y. and Weaver, C. T., Regulatory T cells expressing interleukin 10 develop from Foxp3 +and Foxp3- precursor cells in the absence of interleukin 10. Nat. Immunol. 2007. 8: 931-941.
61. Lahl, K., Loddenkemper, C., Drouin, C., Freyer, J., Arnason, J., Eberl, G., Hamann, A. et al., Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J. Exp. Med. 2007. 204: 57-63.
62. Lahl, K. and Sparwasser, T., In vivo depletion of FoxP3+ Tregs using the DEREG mouse model. Methods Mol. Biol. 2011. 707: 157-172.
63. Mangan, N. E., van Rooijen, N., McKenzie, A. N. J. and Fallon, P. G., Helminth-modified pulmonary immune response protects mice from allergen-induced airway hyperresponsiveness. J. Immunol. 2006. 176: 138-147.
64. Roederer, M., Spectral compensation for flow cytometry: Visualization artifacts, limitations, and caveats. Cytometry 2001. 45: 194-205.